Effects of diet and antihyperglycemic drugs on erectile dysfunction: A systematic review

G Defeudis, R Mazzilli, AM Di Tommaso… - …, 2023 - Wiley Online Library
Background Erectile dysfunction is recognized as one of the complications of diabetes
mellitus. To date, a wide gap of knowledge is present on the efficacy of pharmacological …

[HTML][HTML] Recent advances in new-onset diabetes mellitus after kidney transplantation

T Montada-Atin, GVR Prasad - World Journal of Diabetes, 2021 - ncbi.nlm.nih.gov
A common challenge in managing kidney transplant recipients (KTR) is post-transplant
diabetes mellitus (PTDM) or diabetes mellitus (DM) newly diagnosed after transplantation, in …

JAK2 wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy

N Gangat, N Szuber, H Alkhateeb… - Blood, The Journal …, 2021 - ashpublications.org
Erythrocytosis referrals to hematology are frequently triggered by hemoglobin and
hematocrit (Hgb/Hct) levels that exceed conventional criteria thresholds for polycythemia …

[HTML][HTML] Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study

CKH Wong, KTK Lau, EHM Tang, CH Lee… - Cardiovascular …, 2022 - Springer
Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have proven
cardiovascular benefits in patients with type 2 diabetes (T2D). This self-controlled case …

[HTML][HTML] Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review

B Chin-Yee, M Matyashin, I Cheong, P Bhai… - … Open Access Journal, 2022 - cmajopen.ca
Background: Molecular testing for JAK2 mutations is part of the standard diagnostic workup
for patients with suspected polycythemia vera. We sought to characterize evolving practice …

Sodium-glucose co-transporter 2 inhibitors and erythrocytosis: a review

N Shah, T Bandara, H Deshmukh, L Batten, C Walton… - 2022 - 192.248.48.160
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a class of anti-hyperglycaemic
agents widely used in the treatment of type 2 diabetes mellitus (T2DM). They function by …

[PDF][PDF] Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review

MM BMSc, IC BMSc, I Chin-Yee, C Hsia - cmajopen.ca
Background: Molecular testing for JAK2 mutations is part of the standard diagnostic workup
for patients with suspected polycy themia vera. We sought to characterize evolving practice …

[CITATION][C] Sodium‐glucose cotransporter‐2 inhibitor‐associated erythrocytosis: A retrospective cohort study

J Liu, B Chin‐Yee, IH Chin‐Yee, J Ho… - Journal of Internal …, 2024 - Wiley Online Library